Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$47.36 -1.18 (-2.43%)
As of: Aug 20, 2026 · 3:56 PM EDT

Supernus Pharmaceuticals (SUPN) Gross Margin (QoQ) (2013 - 2025)

Supernus Pharmaceuticals (SUPN) Gross Margin (QoQ) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.85 Bn 42.88 Bn -
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn -
10 Supernus Pharmaceuticals 2.75 Bn 2.38 Bn 185.39 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -100.00
Sep 30, 2025 30.00
Jun 30, 2025 35.00
Mar 31, 2025 446.00
Dec 31, 2024 -498.00
Sep 30, 2024 64.00
Jun 30, 2024 71.00
Mar 31, 2024 59.00
Dec 31, 2023 79.00
Sep 30, 2023 282.00
Jun 30, 2023 -30.00
Mar 31, 2023 -154.00
Dec 31, 2022 87.00
Sep 30, 2022 -256.00
Jun 30, 2022 -27.00
Mar 31, 2022 -107.00
Dec 31, 2021 150.00
Sep 30, 2021 553.00
Jun 30, 2021 -629.00
Mar 31, 2021 149.00